Join Dennis Boyle, IDEO co-founder/partner, and Delphine Huang, IDEO Medical Director, for a 2.5-hour interactive workshop on brainstorming as a team in a digital/remote setting. Focused specifically on health early-stage startups and Rosenman founders, we will be covering how to use design-thinking techniques and tools to creatively brainstorm, synthesize insights, and move towards iterative prototyping.
IDEO is a global design company. They create a positive impact through design.
Our Workshops are hosted by leading experts who have generously offered their services pro bono to our entrepreneurs.If you are selected, we will require a $100 credit card deposit. The deposit will be refunded the day after you attend. No-shows will not receive a refund. Please be punctual; arrivals late by more than 15 minutes will be considered no-shows. If you find that you are unable to attend, you may request a refund up to 5 days in advance. (This will give us time to offer the slot to the first person on the waitlist.) We regret that we cannot honor requests made at a later time.
Most emerging companies with rapid growth plans will seek venture financing. Whether you sell SAFE, convertible notes, or preferred stock, venture investors expect that your financing will feature standard rights and use accepted documentation, but that isn’t the end of the story. Decisions about valuation, founders’ rights, and control over decision making can have long-lasting impacts on the company, and the interests of the investors will quickly deviate from those of the original stockholders. It is important to understand the financing process, where there is room to negotiate, and which investor rights are non-negotiable. This talk will walk through the process of a typical venture investment, starting at the term sheet stage and moving through the definitive documents. We will focus on real-life examples and the consequences of certain decisions in the lead-up to closing.
Speaker: Glen Tullman, Founder & Managing Partner, 7wireVentures; Founder & Former Executive Chairman, Livongo Health
Zoom Webinar Tuesday, January 26, 1:00 to 2:00 PM PST
Livongo Health is one of the biggest all-time successes in digital health. The company “offers a whole person platform that empowers people with chronic conditions to live better and healthier lives.” In 2019, Livongo made its debut on the Nasdaq at $355 million, and saw a premium of nearly 45% over its IPO price. Now, a year later, telehealth giant Teladoc is merging with Livongo in a deal worth as much as $18.5 billion, reflecting the growing importance of virtual healthcare platforms. Join us to hear founder Glen Tullman’s story of how he built Livongo.
Speakers: Rachel Zeldin, Health & Life Sciences practice group at Oliver Wyman
https://www.youtube.com/watch?v=sdSKxs5OxWc
Zoom Webinar Wednesday, January 20, 1:00 to 2:00 PM PST
Employers are a critical stakeholder in the US healthcare system: 49% of Americans receive health coverage through their employer, and employers spend $1.2T on healthcare today. Given this, the employer market is a natural starting point for emerging healthcare companies. But what do employers want, and how is this changing? How should emerging healthcare companies position themselves to address employer concerns? How should healthcare companies selling directly to employers think about other market stakeholders – brokers, health plans, PBMs, providers? During this talk, we will address all three of these questions, and share lessons learned from healthcare technology companies that have built successful businesses in the employer-sponsored market.
Zoom Webinar Tuesday, December 8, 1:00 to 2:00 PM PST
Agreements are the lifeblood of any emerging company. License agreements typically allow founders to bring their technology out of the academic setting and into their companies. Master service agreements are a very common avenue by which emerging companies work with vendors to accomplish research objectives. Collaboration agreements typically define relationships between a company and an industry partner or larger strategic. Understanding these agreements and avoiding pitfalls are critical. This talk with explain the different aspects of such agreements and how they are viewed by venture investors and other strategic partners.
Zoom Webinar Wednesday, November 11, 1:00 to 2:00 PM PST
2020 has been an unbelievably difficult year for everyone and has thrown special obstacles in the way of startup founders. Doing labwork, pitching investors, conducting trials: it can seem like nothing is easy or even possible. Yet you can make progress. Who could confirm this better than Harith Rajagopalan, CEO of Fractyl? Fractyl, whose technology treats patients with type 2 diabetes, received an Investigational Device Exemption from the FDA this June; and in August closed a $55 million round to fund global clinical trials. How did Harith do it?
Speaker: Matt Abrahams, Co-Founder & Principal, BoldEcho
Zoom Webinar Tuesday, December 1, 1:00 to 2:00 PM PST
Audiences crave authentic, bold communication, however, many presenters are uneasy speaking in public. Learn proven concepts to help reduce your anxiety and improve your story telling and audience engagement. You will leave this session with several techniques for developing and delivering clear, confident, and compelling presentations that will make you and your communication “audience ready.”
Zoom Webinar, 1:00 to 2:00 PM PT, Thursday, May 13
https://www.youtube.com/watch?v=IeHIjqbjXXc
The cost of healthcare drives stakeholder interest in reimbursement. Before investors risk their money, they want to know about coverage, coding, and payment. Payers expect better outcomes at equal or lower cost. Hospitals are establishing value analysis committees. Physicians want products that help them meet metrics. And patients are becoming more educated and prefer interventions that improve quality of life at the lowest cost.
Until recently the main focus for health technology companies was FDA clearance. That is still important, but reimbursement is now a top concern. Join this session to learn the basics of reimbursement and how you can develop an integrated clinical plan.
Zoom Webinar Thursday, October 22, Noon to 1:00 PM PST
Startup founders put years of blood, sweat, and tears into their companies, often with the end goal of strategic acquisition. All their work may be in vain, though, if they have not thought and planned in advance about the strategic needs of the acquirer. Understanding how strategics do their due diligence, the key areas/metrics they look for to make the acquisition and the areas they will be interested in when your technology is ripe for acquisition.
What should YOU be thinking about?
Join us to learn from Holly Sheffield, president of CooperSurgical, a leading medtech company that has acquired more than 13 companies in the past 5 years. Prior to joining CooperSurgical, Ms. Sheffield had a 20+ year career as an investment banker, advising companies on strategic acquisitions.
Speaker: Dave Jackson, Founder & CTO, Green Mars Consulting
Zoom Webinar Tuesday, September 29, 2:00 to 3:00 PM PST
The cloud is ubiquitous; everyone needs it, everyone uses it. But to use it right and use it well for business, there are some core considerations: How do you build software in the cloud that will scale? How do you built it to be secure? How do you manage a large user base across a set of very different services? The list of considerations grows when you look more specifically at healthcare in the cloud. Then you also have to think about patient data anonymization, regulatory issues, medical-specific domain technologies in the cloud, performance, and availability to meet the demands of patient care.